GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹4,963 Cr | ₹3,342 Cr | ₹1,858 Cr | ₹3,665 Cr | ₹3,101 Cr |
What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹4,963 Cr |
| Mar2025 | ₹3,342 Cr |
| Mar2024 | ₹1,858 Cr |
| Mar2023 | ₹3,665 Cr |
| Mar2022 | ₹3,101 Cr |
How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,963 Cr | 48.52 | |
| Mar2025 | ₹3,342 Cr | 79.83 | |
| Mar2024 | ₹1,858 Cr | -49.30 | |
| Mar2023 | ₹3,665 Cr | 18.19 | |
| Mar2022 | ₹3,101 Cr | - | |
Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹60,097.3 Cr | -4.2% | -13.5% | 17% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -4.2% |
-13.5% |
17% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses